Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

Discover why emerging market equities are rebounding, key investment themes, and how to capitalize on growth and valuations.

Find out if you're owed money from this settlement and how much you could receive from the $177 million fund before it's too ...

Overview:  IITs offer several pathways beyond the JEE, providing students with access to world-class learning through online degrees, international routes, ...

There are lots of AI stocks that will play important roles in 2026, but if I had to choose three to buy right now, my picks ...

For the quarter ended September 30, 2025, Calamos Growth And Income Fund returned 8.00% (Class I shares at NAV) versus the ...

Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...

Victoria University from Melbourne is expanding to Gurugram, Delhi NCR, launching its first international campus in India in ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread ...

If you're at AT&T customer who qualifies for a payout from this settlement, be sure to claim your share before it's too late.

The two listed share classes of the Columbia Seligman Technology and Information Fund have outperformed the listed competitors for the five-year and 10-year periods. For three years, the DWS Science ...

This phenomenon is at the heart of Paul Wick's skeptical take on early-stage companies that seek to provide nuclear power to data centers and their largest customers, known as hyperscalers, as the ...